Pharmacokinetic models in clinical practice : what model to use for DCE-MRI of the breast?

G.J.S. Litjens, M. Heisen, J. Buurman, B.M. Haar Romenij, ter

Onderzoeksoutput: Hoofdstuk in Boek/Rapport/CongresprocedureConferentiebijdrageAcademicpeer review

12 Citaten (Scopus)


Pharmacokinetic modeling is increasingly used in DCE-MRI high risk breast cancer screening. Several models are available. The most common models are the standard and extended Tofts, the shutterspeed, and the Brix model. Each model and the meaning of its parameters is explained. It was investigated which models can be used in a clinical setting by simulating a range of sampling rates and noise levels representing different MRI acquisition schemes. In addition, an investigation was performed on the errors introduced in the estimates of the pharmacokinetic parameters when using a physiologically less complex model, i.e. the standard Tofts model, to fit curves generated with more complex models. It was found that the standard Tofts model is the only model that performs within an error margin of 20% on parameter estimates over a range of sampling rates and noise levels. This still holds when small complex physiological effects are present.
Originele taal-2Engels
Titel2010 IEEE International Symposium on Biomedical Imaging;14-17 april 2010, Rotterdam, Netherlands
UitgeverijInstitute of Electrical and Electronics Engineers
ISBN van geprinte versie978-1-4244-4125-9
StatusGepubliceerd - 2010


Duik in de onderzoeksthema's van 'Pharmacokinetic models in clinical practice : what model to use for DCE-MRI of the breast?'. Samen vormen ze een unieke vingerafdruk.

Citeer dit